Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial
by
Fogagnolo, Paolo
, Marchina, Daniele
, Caretti, Anna
, Dei Cas, Michele
, Melardi, Ettore
, Quisisana, Chiara
, Rossetti, Luca
in
Age
/ Androgens
/ Double-blind studies
/ evaporative dry eye disease
/ Eye diseases
/ Females
/ Glaucoma
/ Lipids
/ Medical equipment
/ meibomian gland disturbance
/ ocular surface
/ ocular surface disease index questionnaire
/ Original Research
/ Patients
/ Studies
/ tear break-up time (tbut)
2020
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial
by
Fogagnolo, Paolo
, Marchina, Daniele
, Caretti, Anna
, Dei Cas, Michele
, Melardi, Ettore
, Quisisana, Chiara
, Rossetti, Luca
in
Age
/ Androgens
/ Double-blind studies
/ evaporative dry eye disease
/ Eye diseases
/ Females
/ Glaucoma
/ Lipids
/ Medical equipment
/ meibomian gland disturbance
/ ocular surface
/ ocular surface disease index questionnaire
/ Original Research
/ Patients
/ Studies
/ tear break-up time (tbut)
2020
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial
by
Fogagnolo, Paolo
, Marchina, Daniele
, Caretti, Anna
, Dei Cas, Michele
, Melardi, Ettore
, Quisisana, Chiara
, Rossetti, Luca
in
Age
/ Androgens
/ Double-blind studies
/ evaporative dry eye disease
/ Eye diseases
/ Females
/ Glaucoma
/ Lipids
/ Medical equipment
/ meibomian gland disturbance
/ ocular surface
/ ocular surface disease index questionnaire
/ Original Research
/ Patients
/ Studies
/ tear break-up time (tbut)
2020
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial
Journal Article
Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial
2020
Request Book From Autostore
and Choose the Collection Method
Overview
To compare the efficacy of the new lubricating product VisuEvo
(VSE) vs Cationorm
(CTN) in patients with dry eye disease (DED).
Seventy-two patients with evaporative (n=54) and non-evaporative DED (n=18) were included in a multicenter, double-blind, 12-week cross-over study to receive VSE (6 weeks) and CTN (6 weeks) in randomized sequence. After baseline, two visits were performed during each period (intermediate and final visit, respectively at 2 and 6 weeks from the beginning of each period). Primary (tear break-up time, TBUT) and secondary endpoints (Schirmer I, Ferning, blink rate, osmometry, cytokine and lipid expression, ocular surface staining, patient satisfaction, and OSDI score) were compared.
Sixty-three patients were evaluated for efficacy and 68 patients for safety. The intergroup differences for mean TBUT values were not significant at any study visit (baseline 3.2 ±1.5 sec; intermediate visits 4.5 ± 1.9 and 4.5 ± 1.8 sec in VSE and CTN groups, respectively, p = 0.10; final visits 5.4 ± 2.4 and 6.0 ± 3.1, respectively, p=0.63). Also, the assessment of secondary endpoints showed no significant difference between the two groups. The two study treatments were equally effective in evaporative and non-evaporative DED. The safety profile was excellent for both ocular treatments; transient blurred vision was observed in 11 patients only during CTN, 10 patients only during VSE, and 16 during both treatments.
VSE was non-inferior to CTN in restoring tear film composition, increasing its stability and reducing ocular surface damage in evaporative and non-evaporative DED patients.
NCT03833882.
Publisher
Taylor & Francis Ltd,Dove,Dove Medical Press
Subject
MBRLCatalogueRelatedBooks
Related Items
Related Items
This website uses cookies to ensure you get the best experience on our website.